Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finerenone Plus SGLT2 Inhibitor in Heart Failure
NCT07351864Phase 4Active, not recruiting
- Sponsor
- Mansoura University
- Start
- Jan 2026
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of finerenone in heart failure (HF), sponsored by Mansoura University. Started Jan 2026; status: active, not recruiting.
02
Drugs
finerenone
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT07351864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07351864.